Glucagon Like Peptide 2 And Intestinal Adaptation An Hi 2003 The Journal Of

This research examines how a hormone called glucagon-like peptide-2 (GLP-2) helps the intestines adapt and heal after injury or surgical removal of sections. When parts of the small intestine are removed due to disease or surgery, the remaining intestine can actually grow larger and work harder to compensate - a remarkable process called intestinal adaptation. Scientists have identified three main factors that drive this healing: nutrition from food, digestive juices from the pancreas and liver, and hormones like GLP-2.

The most compelling evidence for GLP-2's importance came from studying a unique patient about 30 years ago who had a kidney tumor that was producing large amounts of this hormone. This patient developed massive enlargement of her small intestine. When surgeons removed the tumor, her hormone levels returned to normal and her intestines shrank back to regular size, proving that GLP-2 was directly causing the intestinal growth.

GLP-2 has several beneficial effects on digestion: it reduces stomach acid production, improves sugar absorption in the intestines, and slows down how quickly food leaves the stomach. Most importantly, it acts as a growth factor that helps intestinal cells multiply and the intestinal lining thicken, making nutrient absorption more efficient.

This research has significant implications for metabolic health because a healthy, well-functioning intestine is crucial for proper nutrient absorption and maintaining stable blood sugar levels. In clinical practice, synthetic versions of GLP-2 are now being developed as treatments for patients with short bowel syndrome and other conditions where the intestines need help healing and adapting.